Among PD-L1–positive cases (low and high expression), CPS consistently showed higher expression in oropharyngeal cancers across all specimen types, whereas TPS displayed variable patterns between oropharyngeal and oral cavity tumors. This evidence concerns the gene CD274 and oropharynx cancer.